Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02108041 · ClinicalTrials.gov registry record
Personalized Medicine Decision-Making in a Virtual Clinical Setting
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 196
- Enrollment target
NCT02108041: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT02108041 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 196 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02108041 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
Background: -How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice. Objective: -To study how physicians make personalized treatment decisions Eligibility: -Healthy adult primary care physicians who are internal (or family) medicine residents. Design: * Participants will complete a screening form. * Participants will put on a headset, called a head-mounted display, showing a virtual reality environment. * The environment will contain an exam room and the virtual patient. * After interacting with the virtual patient, participants will complete a series of survey measures. * Participation will last for about 60 minutes. The virtual patient interaction and follow-up questions will be audio taped.
Primary Outcome
To explore how physicians use genetic testing for anticoagulant (warfarin) dosage in patients of different racial /ethnic and SES backgrounds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Est. Completion | 2020-10-08 |
What the finished NCT02108041 record still lists
NCT02108041 is an observational study that tracks outcomes without assigning an intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02108041 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02108041 about?
NCT02108041 is a clinical study titled "Personalized Medicine Decision-Making in a Virtual Clinical Setting". Background: -How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice. Objective: -To study how...
What is the current status of trial NCT02108041?
This trial is currently completed. The enrollment target is 196 participants. Estimated completion is 2020-10-08.
Who is sponsoring clinical trial NCT02108041?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury